Clinical Trial

Macular Degeneration Clinical Trial 20213033

[LCID Study Number: 20213033]

A Study to Genetically Define Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration

The purpose of this study is to evaluate subjects with geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD) by sequencing selected genes associated with AMD.

Disease/Condition: Macular Degeneration

Department: Ophthalmology

Location(s): Lahey Hospital & Medical Center (Burlington); Lahey Medical Center, Peabody

Clinical Trial Details

Protocol #: 20213033

Principal Investigator(s): Jeffrey A. Chang

Study Coordinator(s): Jeffrey A. Chang

Trial Phase: Sponsor Initiated Study Observational